| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 01/05/2010 | US7642362 Compounds as semaphorin inhibitors |
| 01/05/2010 | US7642283 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing the complex to a compound such as 6-bromo-3-methylene-chroman-4-one |
| 01/05/2010 | CA2426467C Composition comprising 8-prenylnaringenin for treatment of skin |
| 01/05/2010 | CA2358923C Water-soluble rhodamine dyes and conjugates thereof |
| 12/31/2009 | US20090326015 Compounds with embedded benzopyran motif for core structures and preparation method thereof |
| 12/31/2009 | US20090325930 Selective estrogen receptor modulator |
| 12/31/2009 | US20090325900 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/31/2009 | US20090324489 Wortmannin conjugates and uses thereof |
| 12/30/2009 | WO2009158516A1 Schweinfurthin analogues |
| 12/30/2009 | WO2009158426A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 12/30/2009 | WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | WO2009156459A1 Organic compounds |
| 12/30/2009 | WO2009156324A2 Use of benzotropolone derivatives as uv absorbers and antioxidants and their use in sunscreens and/or cosmetic compositions |
| 12/30/2009 | WO2009064210A3 Process for the preparation of 2h-chromene-3-carbamate derivatives |
| 12/30/2009 | CN101616906A Photochromic materials demonstrating improved fade rates |
| 12/30/2009 | CN101613337A Method for preparing salicyl fluorone |
| 12/30/2009 | CN101613336A Method for preparing 3 substituted 4-hydroxy coumarin derivative |
| 12/30/2009 | CN101613335A Natural product 5,7-dimethoxy-4'-hydroxyisoflavone preparation method |
| 12/30/2009 | CN101613334A Flavonoid derivative and medical application thereof |
| 12/30/2009 | CN101613333A Method preparing apigenin and application thereof |
| 12/30/2009 | CA2729257A1 Schweinfurthin analogues |
| 12/30/2009 | CA2729217A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 12/29/2009 | US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| 12/29/2009 | US7638640 total pomegranate tannins (TPT) including punicalagin; nutraceutical for cardiovascular health |
| 12/29/2009 | US7638554 e.g. 2-(3,4,5-TRIMETHOXYPHENYL)-3,4-DIHYDRO-2H-BENZO[H]CHROMEN-4-OL; stimulating the endogenous production of a metalloproteinase inhibitor; useful for treating cancer of the brain, breast, ovary, prostate, lung, kidney or colon |
| 12/29/2009 | US7637963 Unsubstituted and polymeric fluoran colorants for coloring consumer products |
| 12/29/2009 | CA2411058C Skin treatment using a new retinoid |
| 12/29/2009 | CA2348695C Method of preparing delta-9-tetrahydrocannabinol esters |
| 12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090318546 Chromen-2-One Derivatives |
| 12/23/2009 | EP2134678A2 N-(5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | CN101610752A 化妆品 Cosmetic |
| 12/23/2009 | CN101607953A Method for preparing phenylfluorone |
| 12/23/2009 | CN101607087A Combinations of dmxaa and other anti-cancer agents |
| 12/23/2009 | CN101606955A Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone |
| 12/23/2009 | CN100572374C Puerarin derivatives and their medical uses |
| 12/23/2009 | CN100572373C Process for preparing scutellarin |
| 12/22/2009 | US7635779 7-(3-tert-Butylamino-2-hydroxy-propoxy)-3',5'-dibenzyloxy-flavone, for example; for treating type II diabetes and associated hyperlipidemic conditions in a mammal |
| 12/22/2009 | US7635778 For example, 3-ethylcarbonate-2-(4-(3-ethylcarbonate-4-oxo-4H-chromen-2-yl)phenyl)-4H-chromen-4-one; authentication markers for use in data storage media substrates |
| 12/22/2009 | US7635715 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4 |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |
| 12/17/2009 | WO2009152210A2 Coumarin compounds and their use for treating cancer |
| 12/17/2009 | WO2009151770A2 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | US20090312408 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors |
| 12/17/2009 | US20090312407 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of Cancer and other Pathologies |
| 12/17/2009 | US20090311163 Drug, drug guidance system, magnetic detection system, and drug design method |
| 12/17/2009 | US20090309076 Photochromic compounds |
| 12/17/2009 | DE112007003075T5 Verfahren zur Acylierung organischer Hydroxyverbindungen A process for the acylation of organic hydroxy compounds |
| 12/16/2009 | EP1737812B1 Methods of amination |
| 12/16/2009 | EP1660074B1 7-carboxymethyloxy-3 , 4 , 5-trimethoxy flavone monohyd rate, the preparation method and uses thereof |
| 12/16/2009 | CN101605772A Novel methylated catechin and composition containing the same |
| 12/16/2009 | CN101605771A 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 12/16/2009 | CN101602755A Method for synthesizing 9, 11-dimethyl-2-oxaspiro [5, 5]-undecanoic-3-one |
| 12/16/2009 | CN101602754A Flavanone derivatives, preparation method and use thereof |
| 12/16/2009 | CN101601996A Catalyst for preparing 1, 8-naphthalic anhydride |
| 12/16/2009 | CN100569780C Fleshy glossy ganoderma lactone A, preparation process and use thereof |
| 12/15/2009 | US7632975 Process for the synthesis of arylfluorenes and analogs thereof |
| 12/15/2009 | US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632861 1-Isobenzofuranethanamine, 1-[[[3,5-bis(trifluoromethyl)phenyl]methoxy]methyl]-1,3-dihydro-N,N-dimethyl-; use in treating a disorder associated with aberrant levels of tachykinins or serotonin; nerve system disorders |
| 12/15/2009 | CA2405747C Aminoflavone compounds, compositions, and methods of use thereof |
| 12/15/2009 | CA2276306C Loss of imprinting-based in vitro diagnostic method to determine the propensity to develop cancer |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | WO2009147645A1 Method for the preparation of c-4 coupled flavonoids, proanthocyanidins and analogues thereof |
| 12/10/2009 | WO2009147057A1 Polymerizable type ii photoinitiators and curable compositions |
| 12/10/2009 | WO2009147054A1 Multifunctional type ii photoinitiators and curable compositions |
| 12/10/2009 | WO2009116883A8 Process |
| 12/10/2009 | WO2009111428A3 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 12/10/2009 | WO2009096702A3 Novel organic dye and method for preparing same |
| 12/10/2009 | US20090306413 Method for preparing 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-acetoxyromane-precursor- alpha-cehc precursor |
| 12/10/2009 | US20090306411 Process for preparing unsaturated lactones |
| 12/10/2009 | US20090306386 Plant Extract Obtained by an Extraction Method by Means of Solvents of Plant Origin |
| 12/10/2009 | US20090306384 Process for the Production of Benzopyran-2-ol Derivatives |
| 12/10/2009 | US20090306197 Substituted Chromanol Derivatives and Their Use |
| 12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
| 12/10/2009 | US20090305410 Fluorescent compounds |
| 12/10/2009 | CA2726277A1 Method for the preparation of c-4 coupled flavonoids, proanthocyanidins and analogues thereof |
| 12/09/2009 | EP2130826A1 Annulins A, B, C or analogs as indoleamine 2,3-dioxygenase (IDO) inhibitors for treatment of cancer |
| 12/09/2009 | EP2130818A1 Multifunctional Type II photoinitiators and curable compositions |
| 12/09/2009 | EP2130817A1 Polymerizable Type II photoinitiators and curable compositions |
| 12/09/2009 | EP1735296B1 Materials and methods for treating coagulation disorders |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | CN101600713A Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
| 12/09/2009 | CN101597274A Preparation method of epicatechin |
| 12/09/2009 | CN101597273A Preparation method of oligomer grape seed procyanidin |
| 12/09/2009 | CN101597272A Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof |
| 12/09/2009 | CN101597271A Iguratimod derivatives, preparation method thereof and pharmaceutical use thereof |
| 12/09/2009 | CN101596187A Anti-cancer combinations |
| 12/09/2009 | CN101596186A Anti-cancer combinations |
| 12/09/2009 | CN100567303C Coumarether compound and use of its composition |
| 12/09/2009 | CN100567284C Method for removing residual minim chloroform from tea polyphenol |
| 12/09/2009 | CN100567283C Flavane compounds and use thereof |
| 12/09/2009 | CN100566728C Method for extracting bitter buckwheat flavone in high purity |
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |